|
Volumn 45, Issue 4, 2014, Pages 1108-1114
|
Combination treatment with N-acetyl-seryl-aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after stroke
a a,c a a a b b a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALTEPLASE;
FIBRIN;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
SERASPENIDE;
SODIUM CHLORIDE;
TRANSFORMING GROWTH FACTOR BETA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BLOOD BRAIN BARRIER;
BLOOD VESSEL PERMEABILITY;
BRAIN BLOOD VESSEL;
BRAIN HEMORRHAGE;
BRAIN INFARCTION SIZE;
BRAIN ISCHEMIA;
CAPILLARY PERMEABILITY;
CEREBROSPINAL FLUID;
CEREBROVASCULAR ACCIDENT;
CONTROLLED STUDY;
ENZYME IMMUNOASSAY;
FIBRINOLYTIC THERAPY;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
IMMUNOHISTOCHEMISTRY;
IN VITRO STUDY;
MALE;
MICROVASCULAR ENDOTHELIAL CELL;
NEUROLOGIC DISEASE;
NEUROPROTECTION;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
THROMBOCYTE;
CAPILLARY PERMEABILITY;
ISCHEMIA;
STROKE;
ANIMALS;
BLOOD-BRAIN BARRIER;
DISEASE MODELS, ANIMAL;
DRUG THERAPY, COMBINATION;
ENDOTHELIAL CELLS;
FIBRINOLYTIC AGENTS;
GROWTH INHIBITORS;
HUMANS;
INTRACRANIAL EMBOLISM;
MAGNETIC RESONANCE IMAGING;
MALE;
NEUROPROTECTIVE AGENTS;
NF-KAPPA B;
OLIGOPEPTIDES;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
PRIMARY CELL CULTURE;
RATS;
RATS, WISTAR;
STROKE;
TISSUE PLASMINOGEN ACTIVATOR;
TRANSFORMING GROWTH FACTOR BETA1;
|
EID: 84897372521
PISSN: 00392499
EISSN: 15244628
Source Type: Journal
DOI: 10.1161/STROKEAHA.113.004399 Document Type: Article |
Times cited : (24)
|
References (0)
|